Costs of rheumatoid arthritis in Hungary

scientific article published on 01 June 2007

Costs of rheumatoid arthritis in Hungary is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID17552071

P2093author name stringLászló Czirják
Zoltán Szekanecz
Gisela Kobelt
Márta Péntek
Valentin Brodszky
László Gulácsi
Bernadette Rojkovich
Gyula Poór
György Genti
István Májer
Anna Polgár
Csaba György Kiss
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
P304page(s)1437
P577publication date2007-06-01
P1433published inThe Journal of RheumatologyQ7743623
P1476titleCosts of rheumatoid arthritis in Hungary
P478volume34

Reverse relations

cites work (P2860)
Q64981700A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases.
Q36516361Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.
Q92188732Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania
Q47633995Annual costs of rheumatoid arthritis in Turkey
Q38212141Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
Q45983817Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010.
Q92139201Cost-of-illness studies in nine Central and Eastern European countries
Q51153107Costs of dementia in Hungary.
Q53107390Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.
Q39191669Economic burden of long-term care of rheumatoid arthritis patients in Hungary
Q48707771Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis
Q80162311The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience
Q38212140Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
Q45308690Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

Search more.